Stifel Maintains Medtronic(MDT.US) With Hold Rating, Maintains Target Price $87

斯迪富維持美敦力(MDT.US)持有評級，維持目標價87美元

moomoo資訊 · 11/20 08:33 · 評級/大行評級

Stifel analyst Rick Wise maintains $Medtronic (MDT.US)$ with a hold rating, and maintains the target price at $87.

According to TipRanks data, the analyst has a success rate of 58.1% and a total average return of 4.9% over the past year.

AnalystRecentRatingAutoNews_201438_20241120_5e77bd5b0cd08354f017802838aed2e670c417a8_1732116652369330_mm_en

Furthermore, according to the comprehensive report, the opinions of $Medtronic (MDT.US)$'s main analysts recently are as follows:

Analysts highlight that despite FY25's positive indicators for high-single-digit EPS growth, into FY26, challenges such as persistent FX pressures, impacts from new product and capital investments, and slight increases in tax rates are anticipated to constrain a sustainable return to high-single-digit EPS growth rates.
Medtronic's Q2 revenue outperformance was primarily propelled by its cardiovascular, neurology, and diabetes segments. The company also raised its FY25 guidance to between 4.75%-5.0%. Looking ahead to FY26, it is believed that EPS growth may surpass overall top line expansion.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

斯迪富分析師Rick Wise維持$美敦力 (MDT.US)$持有評級，維持目標價87美元。

根據TipRanks數據顯示，該分析師近一年總勝率為58.1%，總平均回報率為4.9%。

AnalystRecentRatingAutoNews_201438_20241120_5e77bd5b0cd08354f017802838aed2e670c417a8_1732116652369330_mm_tc

此外，綜合報道，$美敦力 (MDT.US)$近期主要分析師觀點如下：

分析師強調，儘管25財年每股收益高個位數增長指標樂觀，但持續的外匯壓力、新產品和資本投資的影響以及稅率的小幅提高等挑戰預計將限制可持續地恢復到高個位數的每股收益增長率。
美敦力第二季度營收跑贏大盤主要是由其心血管、神經病學和糖尿病板塊推動的。該公司還將25財年的預期上調至4.75％至5.0％之間。展望26財年，據信每股收益的增長可能會超過整體收入的增長。

提示:

TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。

TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。

分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。

總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。更多信息

Stifel Maintains Medtronic(MDT.US) With Hold Rating, Maintains Target Price $87

Stifel Maintains Medtronic(MDT.US) With Hold Rating, Maintains Target Price $87

風險及免責聲明

聲明